Document is current

Article History

Received: 20 September 2017

Accepted: 25 June 2018

First Online: 4 July 2018

Ethics approval and consent to participate

: Not applicable.

: Written informed consent was obtained from the patient for the publication of this Case report. A copy of the written consent is available for review by the editor of this journal.

: MI received departmental scholarship funds of ≥1,000,000 yen per year for direct expenses from MSD K.K., Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Company Limited, Pfizer Japan Inc., Astellas Pharma Inc., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Company Limited in 2014, from MSD K.K., Bristol-Myers Squibb, BIOTORONIK JAPAN. Inc., Astellas Pharma Inc., Shionogi & Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. in 2015, and MSD K.K., Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, and Otsuka Pharmaceutical Co., Ltd. in 2016. The companies associated with this funding were not involved in the preparation of the manuscript or the decision to publish the present case report. The other authors declare no conflicts of interest in association with the present study.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.